Skip to content

Effect of Using Nanochitosan Versus Calcium Hydroxide as Disinfectant on Pain and Apical Bone Healing

Effect of Using Nanochitosan Versus Calcium Hydroxide as Intracanal Medications on the Postoperative Pain and Apical Bone Healing

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03724266
Enrollment
60
Registered
2018-10-30
Start date
2018-10-31
Completion date
2020-12-31
Last updated
2018-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Healing

Brief summary

Effect of Using Nanochitosan versus Calcium Hydroxide as Intracanal Medications on the Postoperative Pain and Apical Bone Healing

Detailed description

PICO approach P (population): maxillary anterior teeth having necrotic pulp with symptomatic apical periodontitis with evidence of apical radiolucency (minimum size 2 mm x 2 mm). I (intervention):0.2% nanochitosan as intracanal medication. C (control): calcium hydroxide paste intracanal medication. O (outcome): Primary outcome: postoperative pain at time interval 4, 12, 24, 48, 72 hours Secondary outcome: 1. Postoperative pain, swelling, palpation, percussion and mobility at one week, 3, 6, 12 months 2. Number of analgesic tablets used at 4, 12, 24, 48, 72 hours and one week. 3. healing of apical periodontitis using CBCT at 3, 6, 12 months

Interventions

chitosan will be used as intracanal medication

DRUGCalcium Hydroxide

intracanal medication

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

participants should be blinded

Intervention model description

postoperative pain after intervention

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients in good general health. * Patient's age ranging between 20-40 years with no sex predilection. * Maxillary anterior teeth with non-vital pulp and symptomatic apical periodontitis. * Evidence of apical radiolucency (minimum size 2 mm x 2 mm). * Patients' acceptance to participate in the study.

Exclusion criteria

* Medically compromised patients with a severe systemic condition. * Pregnant female patients. * Patients who had taken any antibiotic or analgesics during the past 24 hours. * Presence of a swelling because emergency management may include incision and drainage. * Retreatment cases. * Generalized periodontitis (calculus, deep pockets). * Out of normal variations (open apex- severely curved canal- obstructed canal).

Design outcomes

Primary

MeasureTime frameDescription
change in postoperative pain after intervention of chitosan: NRS4,12,24,27 hourspain assessed by numerical rating scale, pain will be assessed using a numerical rating scale (NRS) which is proven to be a simple, valid, and a reliable pain measurement tool. The NRS consists of a series of numbers from zero to 10 with the end-points representing the extremes of pain as no pain and the worst possible pain. Patients will rank their pain level by making a mark on the number they thought it represented their pain. The pain intensity is assigned into four categorical scores: 1, no pain (score 0); 2, mild (scores 1-3); 3, moderate (scores 4-6); 4, severe (scores 7-10). Pain is evaluated preoperatively and postoperatively after the initial visit at 4, 12, 24, 48, 72 hours

Secondary

MeasureTime frameDescription
change in healing of apical periodontitis3,6,12 monthslinear measurment of apical radiolucency using cone beam computed tomography

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026